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Abstract
Mesenchymal stromal cells (MSCs), given their regenerative potential, are being investigated as a potential 
therapeutic tool for cartilage lesions. MSCs express several bioactive molecules which act in a paracrine 
fashion to modulate the tissue microenvironment. Yet, little is known about the divergence of these signalling 
molecules in different MSC populations. The present study investigated secretomes of stromal cells harvested 
from Hoffa’s fat pad (HFPSCs), synovial membrane (SMSCs), umbilical cord (UCSCs) and cartilage (ACs) 
by quantitative liquid chromatography-mass spectrometry (LC-MS/MS) proteomics. Also, multiplex protein 
arrays and functional assays were performed to compare the constitutive immunomodulatory capabilities 
of different MSCs. Proteins involved in extracellular matrix degradation and inflammation, such as matrix 
metalloproteinases (MMPs), interleukin (IL)-17 and complement factors, were downregulated in UCSCs 
as compared to adult cell sources. Additionally, secretion of transforming growth factor (TGF)-β1 and 
prostaglandin E2 (PGE2) was enhanced in UCSC supernatants. UCSCs were superior in inhibiting peripheral 
blood mononuclear cell (PBMC) proliferation, migration and cytokine secretion as compared to adult 
stromal cells. SMSCs significantly suppressed the proliferation of PBMCs only if they were primed with 
pro-inflammatory cytokines. Although all cell types repressed human leukocyte antigen-DR isotype (HLA-
DR) surface expression and cytokine release by activated macrophages, only UCSCs significantly blocked 
IL-6 and IL-12 production. Furthermore, UCSCs supernatants increased aggrecan gene expression in two-
dimensional chondrocyte cultures. The data demonstrated that UCSCs displayed superior anti-inflammatory 
and immunosuppressive properties than stromal cells from adult tissues. This allogeneic cell source could 
potentially be considered as an adjuvant therapy for articular cartilage repair.
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Introduction
Articular cartilage lesions associate with pain, 
discomfort and inflammation of the synovial joint, 
which subsequently restrict the function of the 
joint. Mechanical trauma or degenerative disorders 
are the major causes of articular cartilage injuries 
(Chubinskaya et al., 2015). Traumatic cartilage lesions 
may increase the risk of developing osteoarthritis 
(OA) by more than four times (Muthuri et al., 2011). 
This fast-growing chronic disease is expected to 
be the fourth leading cause of disability by 2020 
(Cross et al., 2014). Commonly used surgical and 
nonsurgical OA treatment modalities include intra-
articular injections of soluble materials, such as 
corticosteroids or hyaluronate, autologous blood 
products, nonsteroidal anti-inflammatory drugs 
(NSAIDs) and arthroscopic lavage. These procedures 
improve OA symptoms to a certain degree but do 
not heal completely the progressive loss of joint 
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functions (Lee and Wang, 2017; Wolfstadt et al., 2015). 
Additionally, the treatment of localised cartilage 
injuries with cell-based therapies benefits patients 
with debilitative knee functions and delays the 
onset of secondary OA (Ogura et al., 2017). Although 
autologous chondrocytes are used as an intuitive 
source for cell-based therapy (Knutsen et al., 2016; 
Saris et al., 2014), in recent years, mesenchymal 
stromal cells (MSCs) are gaining attention as an 
alternative and potentially effective therapeutic tool 
for cartilage lesions.
 MSCs are successfully isolated and expanded in 
vitro from numerous tissues sources. MSCs represent 
a defined population of multipotent progenitor 
cells residing in the perivascular niche of nearly all 
human tissues, although different views exist (Crisan 
et al., 2008; Guimaraes-Camboa et al., 2017). MSC 
differentiation capacity and immunomodulatory 
properties are demonstrated in vitro, irrespective of 
tissue sources (Ghannam et al., 2010). However, in 
vitro studies show that MSCs from different origins 
differ in their lineage-specific differentiation capacity 
and their functional potential (Garcia et al., 2016; Islam 
et al., 2016; Subramanian et al., 2015). In addition, a 
systematic review of intra-articular injection of bone 
marrow MSCs in humans has concluded that articular 
stem cell therapies are safe (Peeters et al., 2013). 
Some preclinical studies in animals demonstrate 
the in vivo efficacy of MSCs from different sources, 
including autogenic, allogeneic and xenogeneic, in 
OA management. However, none of these studies 
has compared the optimal source of MSCs (Ozeki et 
al., 2016; Saulnier et al., 2015; Singh et al., 2014; Yang 
et al., 2015). Therefore, the choice of optimal MSC 
source for a given clinical implication has yet to be 
elucidated.
 In mechanistic terms, it is not well established how 
MSCs exert their effects in vivo. Liechty et al. (2000) 
propose that MSCs promote tissue regeneration by 
engraftment of cells in damaged areas and trans-
differentiation into tissue-forming cells to promote 
repair. Recently, paracrine signalling and release of 
potent bioactive factors have emerged as modulators 
of the microenvironment during tissue healing 
(Gnecchi et al., 2016; Iso et al., 2007; Prockop, 2009). 
In the field of cartilage repair and OA, the fate of 
implanted cells during biological repair procedures 
and their contribution to rebuilding the damaged 
tissue is mostly unknown. Previous studies in 
animals suggest that most of the repaired tissue is 
composed of cells of unknown origin migrating to 
the lesion (Dell’Accio et al., 2003; Grande et al., 1989). 
A recent human clinical trial has concluded that 
allogeneic bone marrow MSCs function as a source 
of stimulatory and trophic factors, which orchestrate 
tissue repair rather than differentiating into the host 
tissue (de Windt et al., 2017).
 Clinical procedures based on autologous MSC 
transplantation, including bone marrow or adipose 
tissue MSCs, may provide beneficial effects, but are 
associated with invasive harvesting procedures, two-
stage operations and long-time cell expansion ex vivo. 
Allogeneic MSCs harvested from umbilical cords, 
amniotic membrane and placenta might represent 
alternative sources for one-stage cell-based therapies. 
In addition to their pro-angiogenic properties, 
anti-inflammatory phenotype and multi-lineage 
differentiation potential, these allogeneic MSCs are 
well tolerated and elicit low immunogenic responses 
as their adult counterparts (Balasubramanian et 
al., 2012; Donders et al., 2015). Differently from the 
investigation into the neo-tissue-forming ability, the 
role of secreted bioactive molecules in the context of 
paracrine signalling and immunomodulation have 
not been comprehensively explored between cells 
from adult joints and young cells. The aim of the 
present study was to find the most suitable cell source 
to promote immunomodulation and chondrogenesis 
from the paracrine signalling perspective. The 
number of published studies presenting comparative 
analyses of secretory profiles between different cell 
types is very limited (Amable et al., 2014; Dabrowski 
et al.., 2017). Among those, the present study was the 
only one applying both large-scale secretomics and 
multiplex protein analyses and integrating functional 
immune assays to validate the results.
 The present study compared the secretome of 
culture-expanded cells harvested from four different 
tissues sources comprising articular cartilage 
(ACs), Hoffa’s fat pad stromal cells (HFPSCs), 
synovial membrane stromal cells (SMSCs) and 
umbilical cords stromal cells (UCSCs). For analyses, 
mechanisms and pathways relevant to cartilage 






1 M 40 I/II
2 F 46 II/III
3 M 47 II/III
4 F 54 II
5 F 60 III
6 M 60 II
7 M 61 III
8 F 67 III
9 F 70 II
10 F 70 III
11 F 71 II/III
12 M 73 III
13 M 74 III
14 M 76 II/III
15 M 77 III
Table 1. Demographics of patients from which 
cells were isolated. M: male; F: female; ICRS: 
International Celestial Reference System (van den 
Borne et al., 2007).
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immune regulation, extracellular matrix (ECM) 
remodelling, mitotic factors and chondro-inductive 
molecules, were considered. Proteins involved in 
ECM remodelling, such as matrix metalloproteinases 
(MMPs), complement factors and serpins, were 
significantly downregulated in UCSCs as compared 
to other cell types, whereas cell signalling molecules, 
such as transforming growth factor (TGF)-β1, 
monocyte chemoattractant protein-1 (MCP-1) and 
platelet derived growth factor D (PDGFD), were 
upregulated in UCSCs. Additionally, the effects of cell 
supernatants on cartilage signature genes expression 
in two-dimensional (2D) chondrocyte culture were 
investigated. UCSCs significantly enhanced the 
expression of aggrecan gene by dedifferentiated 
chondrocytes. To evaluate the constitutive abilities 
of the different MSCs as immunomodulators, the 
immunoregulatory properties of supernatants from 
the different cell types were compared by functional 
immune assays. Data revealed that UCSCs exhibited 
superior anti-inflammatory properties and low 
catabolic phenotypes as compared to ACs, HFPSCs 
and SMSCs.
Materials and Methods
Human materials and ethical statements
Human samples were collected from the University 
Hospital of Northern Norway (UNN). The Regional 
Ethical Committee (REK Nord 2014/920 and 
2010/586) at the University of Tromsø approved 
the study. Adult stromal cells were isolated from 
knee joint tissues of 15 patients (40-77 years old) 
undergoing total knee replacement (TKR). Patients’ 
demographics are summarised in Table 1. A 
macroscopic observation was made by the operating 
surgeon to assess the inflammatory state of the 
sample. Patients with inflammatory joint diseases 
and very advanced OA were excluded; however, both 
secondary post-traumatic and primary OA patients 
were included in the study. Fat pad and synovial 
membrane tissues were harvested from TKR patients. 
UCSCs were isolated from seven umbilical cords 
immediately after birth. Buffy-coats for isolation of 
peripheral blood mononuclear cells (PBMCs) were 
collected from healthy donors from the local blood 
bank (REK Nord 2014/401). All patients provided 
written informed consent.
Isolation and culture of human stromal cells
Macroscopically-normal-looking carti lage, 
corresponding to cartilage areas looking intact to 
the eye and presenting no signs of abnormalities, 
such as tears, scratches, rugose or eroded tissue, 
was collected from femoral condyles during total 
knee replacements and was used to isolate human 
chondrocytes. All cell types were isolated using a 
mixed enzymatic-explant method, as previously 
described (Islam et al., 2016; Islam et al., 2017). Briefly, 
all tissue specimens were washed three times with 
sterile Dulbecco’s phosphate buffered saline (PBS; 
D8537, Sigma-Aldrich) and minced into small pieces 
for subsequent enzymatic digestion in collagenase XI 
solution (≥ 800 units/mg solid; C9407, Sigma-Aldrich) 
at a final concentration of 1.25 mg/mL at 37 °C on a 
shaker at 400 rpm. Cartilage tissue specimens were 
digested for 3-4 h, other adult tissue specimens were 
digested only for 1-1.5 h. UCSCs were isolated from 
40 mm-long cord fragments (also known as mixed 
cords) previously sterilised by immersion in 90 % 
ethanol for 30 s and enzymatically digested for 
1 h collagenase XI. Partially digested tissues were 
centrifuged for 10 min at 800 ×g and resuspended 
in high-glucose Dulbecco’s modified Eagle medium 
(DMEM; D5796; Sigma-Aldrich) before plating in a 
T-75 culture flask (156499; ThermoFisher Scientific). 
The culture medium was supplemented with 62 mg/L 
L-ascorbic acid (103033E, BDH Laboratory, Pole, UK), 
1 % penicillin and streptomycin (P/S; P4333, Sigma-
Aldrich) and 20 % foetal bovine serum (FBS; S0115, 
Biochrom) to promote cell attachment. All cells were 
incubated in a humidified atmosphere containing 
5 % CO2 at 37 °C. After the initial 24 h, primary 
cultures were expanded in 10 % FBS-supplemented 
medium and the medium was changed every 3-4 d 
until the cultures became confluent. Cells from all 
tissue sources were used for experiments at passage 
(P) 3 and 4.
Preparation of conditioned medium (CM)
Serum-containing CM was used in the functional 
assays with PBMCs and macrophages, whereas 
serum-free CM was used for protein-arrays and 
secretomics. Upon reaching 70-80 % confluence, 
culture flasks were thoroughly washed with warm 
PBS and the medium was replaced with fresh high-
glucose DMEM containing 1 % P/S, with or without 
10 % FBS. Serum-free medium was supplemented 
with 1 µg/mL dexamethasone (PZN-3103491; 
Galenpharma, Kiel, Germany) and 1 : 1000 insulin-
transferrin-selenium supplement (ITS; 354351; 
Corning). For priming of cells with pro-inflammatory 
cytokines, growth media were supplemented for 
48 h with 50 ng/mL each of tumour necrosis factor 
alpha (TNF-α; 300-01A, PeproTech) and interferon 
gamma (IFNγ; 300-02, PeproTech). CM was collected 
after 48 h, centrifuged at 4500 ×g for 10 min, filtered 
through a 0.22 µm porous membrane (GSWP04700; 
Millipore) and used immediately for experiments 
or stored at – 70 °C for further analysis. Cells were 
counted for each culture condition and the value used 
to normalise the measured expression of cytokines 
and growth factors in the CM. In functional assays 
with PBMCs and macrophages, the fresh culture 
medium was diluted with serum-containing CM 
(1 : 1) from different stromal cells.
Quantitative and qualitative liquid chromatography-
mass spectrometry (LC-MS/MS) analysis
6 mL of serum-free CM from all cultures were 
collected from T-75 culture flasks and concentrated 
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for 20 min at 4500 ×g in PBS to a final volume of 
500-800 µL using a 5 kDa molecular weight cut-off 
(MWCO) Vivaspin 6 column (Z614440-25EA, Sigma-
Aldrich). Protein concentration was measured using 
DC Protein Assay Kit (5000116, Bio-Rad). Protein 
samples were prepared as described before (Islam 
et al., 2019). Briefly, protein samples (100 µg/tube) 
were reduced in 5 mM dithiothreitol (D9779, Sigma-
Aldrich) for 30 min at 70 °C. Samples were alkylated 
by incubation with 375 mM iodoacetamide (90034, 
ThermoFisher Scientific) at room temperature for 
30 min in the dark. Protein samples were collected 
as dry pellets after overnight precipitation in pre-
chilled acetone (270725, Sigma-Aldrich) at − 20 °C. 
Dry pellets containing 100 µg of protein were 
resuspended in 100 µL of 2 M urea (U1250, Sigma-
Aldrich) with 50 mM triethylammonium bicarbonate 
(TEAB; 90114, ThermoFisher Scientific). Only 25 µg 
of protein per sample were taken for further analysis. 
Samples were pre-digested for 6 h with 1 : 100 (w/w) 
LysC endopeptidase (125-05061, Wako Chemicals, 
Neuss, Germany) with 1 mM final concentration 
of CaCl2, followed by further dilution with 50 mM 
TEAB in 1 M urea and digestion overnight in 1 : 20 
(w/w) trypsin (V511A, Promega). 5 µL trifluoroacetic 
acid (10 %) (28904, ThermoFisher Scientific) were 
added to each tube and centrifuged at 16,000 ×g for 
10 min. OMIX C18 tips were used for sample clean-
up and concentration. Samples containing 0.2 % 
formic acid (FA; 28905, ThermoFisher Scientific) 
were loaded into a ThermoFisher Scientific EASY-
nLC1000 system and EASY-Spray column (C18, 
2 µm, 10 nm, 50 µm, 500 mm). Peptides were 
fractionated using a 2-100 % acetonitrile (51101, 
ThermoFisher Scientific) gradient in 0.1 % FA at a 
flow rate of 250 nL/min over 180 min. The separated 
peptides were analysed using a ThermoFisher 
Scientific Q-Exactive mass spectrometer. Data were 
collected by Top10 method in data-dependent mode. 
The raw data were processed using MaxQuant (v 
1.5.6.0) for label-free protein quantification (LFQ). 
MS/MS data were searched against the UniProt 
human database (Web ref. 1) from November 2016 
to yield protein identification [false discovery rate 
(FDR) = 0.01]. Parameters used for the search: fixed 
modification, carbamidomethylation of cysteines; 
variable modifications, oxidation of methionine and 
acetylation of protein N-terminal; ion mass tolerance, 
4.5 ppm; fragment mass tolerance, 20 ppm; charge 
states, 2+, 3+ and 4+; maximum missed cleavages, 
2; enzyme specificity, trypsin; minimum number 
of unique peptides, 2. Perseus 1.5.6.0 software 
(Max Planck Institute of Biochemistry, Germany) 
was used for statistical analysis of the identified 
proteins. All contaminants were filtered out before 
log10-transformation of data for further analysis. 
The log10-transformed intensities were normalised 
by subtracting the median. Data were grouped as 
ACs, HFPSCs, SMSCs and UCSCs and analysed 
using a t-test, with a minimum of three valid values 
in each group. Volcano plots for each comparison 
were generated to identify differentially expressed 
proteins using FDR < 0.01.
Multiplex protein arrays
A panel of 36 specific proteins including cytokines, 
chemokines, MMPs and growth factors was 
measured in the serum-free CM of all four stromal 
cell types by immune-based protein array. A 
human cytokine magnetic 25-plex kit (LHC0009M, 
ThermoFisher Scientific) was used to measure the 
concentration of 18 cytokines (1 : 4 dilution) involved 
in inflammation – including granulocyte-macrophage 
colony-stimulating factor (GM-CSF), IFN-α, IFN-γ, 
interleukin (IL)-1β, IL-1RA, IL-2, IL-2R, IL-4, IL-5, 
IL-6, IL-7, IL-8, IL-10, IL-12 (p40/p70), IL-13, IL-15, 
IL-17 and TNF-α – and 7 chemokines (1 : 4 dilution) – 
including eotaxin, interferon-gamma-induced protein 
10 (IP-10), MCP-1, MIG, macrophage inflammatory 
proteins (MIP)-1α, MIP-1β and RANTES. Fluorokine 
MAP human MMP base kit (LMP000, R&D Systems) 
was used to measure the concentration of MMP-1, 
MMP-3, MMP-7, MMP-9 and MMP-13 (1 : 5 dilution). 
Quantitative measurements (two replicates) were 
performed according to manufacturers’ guidelines 
using Luminex Bio-Plex 200 system (Bio-Rad). In 
addition, quantification of PGE2 (KGE004B), IL-4 
(DY204-05), IL-10 (DY217B-05) and the five growth 
factors TGF-β1 (DY240-05), BMP-2 (DY355-05), IGF-1 
(DY291-05), PDGF-AB (DY222) and basic fibroblast 
growth factor (bFGF) (DY233-05) was performed 
by enzyme-linked immunosorbent assay (ELISA). 
All ELISA kits were purchased from R&D Systems 
and performed according to the manufacturer’ 
instructions. Measured protein concentrations 
were normalised to cell number at specific culture 
conditions and expressed as pg/mL/106 cells.
Isolation and culture of human PBMCs
PBMCs were isolated from buffy-coats (n = 5) 
of whole blood using Lymphoprep™ (1114545, 
Alere Technologies, Oslo, Norway) following the 
manufacturer’ instructions. Briefly, peripheral blood 
was diluted in sterile PBS (1 : 1) and slowly layered 
over a Lymphoprep™ gradient in a 50 mL tube. 
The tube was centrifuged at 800 ×g for 30 min at 
room temperature. PBMCs were collected from the 
gradient-interface with a Pasteur pipette, followed 
by washing three times for 10 min at 400 ×g with 
phosphate NaCl (PBSA) containing PBS and 0.2 % 
bovine serum albumin (BSA; 130-091-376, Miltenyi 
Biotec). PBMCs were cultured in growth medium 
containing Rosewell Park Memorial Institute medium 
(RPMI-1640; R8758, Sigma-Aldrich), 1 % P/S and 10 % 
FBS in a humidified atmosphere (5 % CO2) at 37 °C.
PBMC proliferation assay
PBMC proliferation was assessed using the 
carboxyfluorescein succinimidyl ester (CFSE) 
dilution assay (10009853, Cayman). Cultured 
PBMCs were washed in pre-warmed sterile PBS and 
centrifuged at 400 ×g for 5 min before incubation with 
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CFSE for 15 min at 1 : 400 dilution. CFSE-stained 
PBMCs were cultured in RPMI, 1 % P/S and 10 % 
FBS in a 24-well plate at a density of 106 cells/well. 
PBMCs were stimulated with 10 µg/mL mitogen 
phytohemagglutinin (PHA; 1249738, Roche) for 5 d 
to induce proliferation. Half of the medium was 
replaced with fresh medium after the second day. The 
proliferation assay was performed on a BD FACSAria 
III flow cytometer (BD Biosciences) and the data were 
analysed by FlowJo software (Tree Star Inc., Ashland, 
OR, USA). CM from stromal cells was added to the 
culture of PHA-activated PBMCs from day 1 at 1 : 1 
ratio with fresh culture medium. CM from the last 
3 d of PBMC proliferation was collected to measure 
cytokine profiles. CM derived from PBMCs was 
centrifuged at 4500 ×g for 5 min and filtered through 
a 0.22 µm porous membrane (GSWP04700; Millipore) 
before analysing TNF-α (DY210-05; R&D Systems) 
and IFN-γ (DY285-05; R&D Systems) content by 
ELISA.
PBMC migration assay
PBMC migration assay was performed by Boyden 
chamber assay (Gorchs et al., 2015). PBMCs were 
activated with 10 µg/mL PHA for 48 h before 
performing the assay. 100 ng/mL recombinant stromal 
cell-derived factor-1 (SDF-1; 300-28A, PeproTech) was 
used as a chemoattractant. 106 cells/100 µL PBMCs 
were added to the top chamber of Corning® Costar® 
Transwell® cell culture inserts (6.5 mm diameter, 
8 µm pores; CLS3464-48EA, Sigma-Aldrich). Bottom 
chambers contained either growth medium or serum-
rich CM from different stromal cells. After 2 h, PBMCs 
that migrated to the lower chamber were harvested 
and washed in PBSA by centrifugation at 400 ×g for 
4 min followed by resuspension in 0.5 mL of PBSA. 
Lymphocytes population was gated using forward 
and side scatter and counted on a BD FACSAria III 
flow cytometer.
Isolation and culture of monocyte-derived 
macrophages
Monocytes were isolated from PBMCs using CD14+ 
magnetic-activated cell sorting (MACS; 130-050-
201, Miltenyi Biotec) with minor modification from 
manufacturer’ guidelines. Briefly, PBMCs were 
washed in MACS buffer containing autoMACS 
rinsing solution (130-091-222, Miltenyi Biotec) 
and BSA (20 : 1) for 10 min at 4 °C. PBMCs were 
incubated with CD14+ microbeads at a concentration 
of 10 µL beads/107 cells in 40 µL of MACS buffer 
for 15 min at 4 °C. PBMCs were rinsed in MACS 
buffer and resuspended in an appropriate volume 
before passing through the MS column. CD14+ 
monocytes were eluted from the column and 
washed with ice-cold MACS buffer. The purity of 
eluted monocytes was checked by flow cytometry 
using anti-CD14-fl uorescein isothiocyanate (FITC)-
conjugated antibody (130-098-063, Miltenyi Biotec) 
and its isotype control mouse IgG2a-FITC (130-098-
877). Fully transformed macrophages (M0-M) were 
achieved after 6 d incubation of CD14+ monocytes in 
a macrophage growing medium containing RPMI-
1640, 1 % P/S, 10 % FBS and 100 ng/mL macrophage 
colony-stimulating factor (M-CSF; 300-25, PeproTech) 
in a humidified atmosphere (5 % CO2) at 37 °C. The 
medium was replaced with fresh medium after 3 d.
Macrophage polarisation assay
For induction of the M1 phenotype (M1-M), 
M0-M were plated in a 6-well plate at a density 
of 2.5 × 106 cells/well and stimulated for 48 h with 
100 ng/mL lipopolysaccharides (LPS; L6529-1MG, 
Sigma-Aldrich) and 20 ng/mL IFN-γ. To investigate 
the effects of cell secretomes on M1-M polarisation, 
macrophage culture medium was diluted with 
serum-rich CM (1 : 1) from different stromal cells. 
Macrophages were harvested after 48 h and washed 
in MACS buffer before analysing on BD FACSAria 
III flow cytometer. FlowJo software was used for 
analysing surface markers expression.
 M1-M polarisation was characterised by surface 
marker expression of CD40 (130-099-385, Miltenyi 
Biotec), CD64 (130-100-415, Miltenyi Biotec), CD80 
(130-110-371, Miltenyi Biotec), CD86 (560957; BD 
Biosciences) and HLA-DR (560943, BD Biosciences). 
All antibodies were phycoerythrin (PE)-conjugated 
and analysed with respective isotype controls, 
including mouse IgG1 (130-098-845, Miltenyi 
Biotec), REA control (130-104-612, Miltenyi Biotec) 
and mouse IgG2a (555574, BD Biosciences). For 
induction of M2 phenotype (M2-M), M0-M were 
stimulated with 4 µg/mL dexamethasone for 48 h 
and characterised by surface marker expression of 
Table 2. qPCR probes.
Gene name Gene symbol Assay ID
Collagen type I α1 COL1A1 Hs00164004_m1
Collagen type II α1 COL2A1 Hs00264051_m1
Aggrecan ACAN Hs00153936_m1
sex determining region Y (SRY)-box 9 SOX9 Hs00165814_m1
Ribosomal protein L13A RPL13A Hs04194366_g1
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CD163-FITC; 130-099-969, Miltenyi Biotec) and its 
isotype control mouse IgG1-FITC (130-098-847). To 
further investigate the effects of CM from all cell types 
on M1-M polarisation, macrophage-CM was collected 
after 48 h, centrifuged at 4500 ×g for 5 min, filtered by 
0.22 µm porous membrane (GSWP04700; Millipore) 
and used immediately for experiments or stored at 
− 70 °C for further analysis. The concentration of 
TNF-α, IL-6 (DY206-05) and IL-12 (DY1240-05) were 
measured by ELISA. All ELISA kits were purchased 
from R&D Systems.
qPCR
Dedifferentiated chondrocytes at P3 were cultured for 
48 h in the presence of stimulated and non-stimulated 
CM. After 48 h, chondrocytes were harvested for 
qPCR to analyse the expression of cartilage signature 
genes. Dedifferentiated chondrocytes at P2 and P3 
grown in the absence of CM were used as controls. 
The qPCR reaction was performed as described 
before (Hansen et al., 2017). Briefly, RNA was 
extracted according to the manufacturer’s guidelines 
using the RNeasy Plus Mini Kit (74134, QIAGEN). 
Each RNA template was reverse transcribed to 
cDNA using the qScript cDNA Synthesis Kit (95047, 
Quanta Biosciences). The qPCR reaction was run on 
a StepOnePlusTM Real-Time PCR system (Applied 
Biosystems). Probes used are summarised in Table 
2. Gene relative expression was presented using the 
ΔCq value (Hansen et al., 2017) and calculated by 
subtracting the gene of interest from the reference 
gene (RPL13A), making higher ΔCq value represents 
increased gene expression and vice versa.
Three-dimensional (3D) cultures
In vitro 3D chondrogenic assays of dedifferentiated 
chondrocytes was performed using a pellet culture 
method as described previously (Islam et al., 
2016). Briefly, chondrocytes were harvested at P3, 
centrifuged in a conical-bottom 96-well plate for 
10 min at 1,100 ×g and incubated in culture medium 
for 48 h in low oxygen (3 % O2) atmosphere. After 
48 h, the newly formed neo-tissues were transferred 
to ultra-low attachment plate and cultured for 21 d in 
serum-free basal chondrogenic medium containing 
high-glucose DMEM, 62 mg/L L-ascorbic acid, 1 % 
P/S, 1 µg/mL dexamethasone, 1 : 1000 ITS in low 
oxygen (3 % O2) atmosphere. Chondrogenesis was 
induced in the control samples by adding 10 ng/mL 
TGF-β1 (100-21C; PeproTech) and 100 ng/mL BMP- 
2 (120-02C; PeproTech) to the basal chondrogenic 
medium. To investigate the effect of stimulated 
and non-stimulated CM on chondrogenesis, the 
spheroids were incubated with CM in the absence of 
growth factors.  Half of the CM was replaced with 
fresh CM twice a week. Spheroids were harvested 
after 21 d and fixed in 10 % formalin overnight for 
histological evaluation. Alcian blue solution (A5268, 
Sigma-Aldrich) was used for metachromatic staining 
of 4 µm-thick paraffin-embedded sections.
Statistical analysis
All statistical analyses were performed using IBM 
SPSS statistics version 24 (Chicago, IL, USA). Data 
were analysed using non-parametric Kruskal-
Wallis test, unless an exception was mentioned, and 
significance values were adjusted by Bonferroni 
correction for multiple comparisons. The level of 
significance was set at p < 0.05. Results are presented 
as density graphs, where each donor plotted as a dot 
in the dataset.
Results
Comparative protein profiles in supernatants of 
different stromal cells by LC-MS/MS proteomics
The MS secretomics data (identifier PXD011762) 
were deposited to the ProteomeXchange Consortium 
through the PRIDE partner repository (Vizcaíno et al., 
2016). All cell types were characterised by MSC surface 
markers and retained similar characteristics, as shown 
by Islam et al. (2016). The cell secretome established 
in serum-free CM from each cell type (four unrelated 
donors per cell type) was analysed by LC-MS/MS 
proteomics. Only proteins identified in at least three 
donors in each group were considered for further 
analyses. Results showed more proteins identified 
in the supernatants of ACs (709) as compared to 
HFPSCs (641), SMSCs (567) and UCSCs (653) (Fig. 
1a). Comparative analysis of identified proteins 
revealed 472 proteins present in the supernatants of 
all four cell types. Only a minor fraction of proteins 
was exclusively found in supernatants of specific 
cell types, including 50 differentially expressed by 
UCSCs, 44 by ACs, 22 by HFPSCs and 2 by SMSCs. 
Hierarchical clustering of identified proteins revealed 
two major clusters, where one cluster comprised 
the four donors of UCSCs and the second cluster 
comprised all stromal cells from adult tissues (Fig. 
1b). Furthermore, among the stromal cells from adult 
tissues, the four AC donors were clearly separated 
from HFPSC and SMSC donors. Identified proteins 
were divided into six groups according to their 
functions using Gene Ontology Biological Process 
(GOBP) terms (Pazos and Chagoyen, 2009) (Fig. 
2a). Qualitative comparison of proteins in different 
pathways revealed no major differences between 
cell sources. Proteins involved in ECM remodelling 
were abundant in the supernatants of all cell types. In 
addition, all stromal cells released similar percentage 
of proteins involved in immunoregulation (~ 20 %) 
and secretion (~ 13 %) (Fig. 2a).
 Quantitative analyses of protein expression were 
performed using the LFQ approach (Patel et al., 2009) 
(Fig. 2b). Six volcano plots representing all possible 
comparisons showed differentially expressed 
proteins by plotting log10 of the fold change on the 
X-axis and − log10 of the p-value on the Y-axis for each 
comparison (e.g. HFPSCs vs. ACs). Results revealed 
the largest differences in protein expression between 
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UCSCs and all other adult stromal cells (FDR < 0.01). 
Proteins involved in cell signalling, such as TGF-β1, 
PDGFD and MCP-1, were significantly upregulated 
in UCSCs (FDR < 0.01), while catabolic proteins, such 
as MMPs, serpins and complement factors, were 
downregulated as compared to stromal cells from 
adult origin (Fig. 2b). Notably, minor differences 
particularly in ECM remodelling proteins, such as 
MMPs and serpins, were observed while comparing 
stromal cells from cartilage and synovium (Fig. 2b). 
Protein profiles belonging to specific pathways (ECM 
remodelling, cell communication and inflammation) 
were compared among the four cell types (Fig. 3). 
Several MMPs, serpins, some complement factors and 
heat shock proteins were significantly downregulated 
in UCSCs (FDR < 0.01). On the other hand, cell 
signalling molecules including MCP-1, integrin 
(ITG)-β1, PDGFD, CSF-1, HLA-C and TGF-β1 were 
more abundant in the supernatants of UCSCs.
Determination of cytokines and growth factors in 
supernatants by multiplex protein arrays
A panel of 18 selected cytokines involved in 
inflammation and immunoregulation was measured 
in the supernatants of all stromal cells. Only IL-4, IL-6, 
IL-8, IL-12 and IL-17 were detected in supernatants 
of all cell types, whereas GM-CSF, IFN-α, IFN-γ, IL-
1β, IL-1RA, IL-2, IL-2R, IL-5, IL-7, IL-13, IL-15 and 
TNF-α were not detected in any of the supernatants. 
From the panel of chemokines, MCP-1, MIP-1α and 
RANTES were detected in all supernatants, but 
eotaxin, IP-10, MIG and MIP-1β were not detected. 
Overall, the levels of IL-6, MCP-1 and PGE2 were 
increased in UCSCs supernatants as compared 
to other cell types, whereas the levels of IL-17, 
MIP-1α and RANTES were decreased (Fig. 4). The 
concentration of IL-17 and MIP-1α was significantly 
lower in the UCSC supernatant as compared to AC 
supernatant and the levels of PGE2 was significantly 
higher in UCSC supernatants as compared to HFPSC 
supernatant (Fig. 4). With regards to the expression of 
proteases, only MMP-13 was not detectable, whereas 
MMP-1, MMP-3, MMP-7 and MMP-9 were detected 
to some degree in all serum-free CM (Fig. 5). The 
secretion of MMP-1, MMP-3, MMP-7 and MMP-9 
was in general lower in UCSCs as compared to all 
other cell types. Significant differences were found 
for MMP-3 and MMP-7 when comparing UCSCs and 
ACs. The anabolic growth factors TGF-β1, BMP-2 and 
bFGF were detected at low levels in supernatants 
of the four cell sources, whereas IGF-1 and PDGF-
AB could not be detected. Additionally, TGF-β1 
was significantly elevated in UCSCs as compared 
to HFPSCs (Fig. 5). To check for possible effects 
of serum supplementation on the production of 
cytokines by MSCs, the expression of TNF-α, IFN-γ, 
Fig. 1. Hierarchical clustering of 
identified proteins from secretomes of 
ACs, HFPSCs, SMSCs and UCSCs. (a) 
Venn diagram depicts the percentage 
of identified proteins shared among the 
four different stromal cell types (n = 4 
donors/cell sources). (b) Dendrogram 
shows two major clusters of four 
different stromal cell types. All cell 
sources from adult mesenchymal origin 
clustered together, whereas the four 
donors of UCSCs from extra-embryonic 
origin clustered separately. 
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Fig. 2. Protein expression analysis by LC-MS/MS from CM of ACs, HFPSCs, SMSCs and UCSCs. (a) 
Distribution of identified proteins into six main categories according to their function annotated using 
GOBP terms. (b) Volcano plots illustrate the results of the six sets of statistical comparisons made between 
HFPSCs vs. ACs, SMSCs vs. ACs, HFPSCs vs. SMSCs, UCSCs vs. ACs, UCSCs vs. HFPSCs and UCSCs vs. 
SMSCs. These plots show each protein with − log10 (p-value) and log10 of fold change of the comparison 
on the Y-axis and X-axis, respectively. Proteins with larger fold change and lower p-value are plotted 
further away from zero on each axis. Proteins that are significantly up- and down-regulated (p < 0.01) are 
represented in green and red, respectively. 
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IL-6 and IL-12 in both serum-containing and serum-
free CM from all four cell types was analysed. From 
the analysed cytokines, only the expression of IL-6 
was considerably changed in the presence of serum 
(Fig. 6).
UCSC supernatants exerted stronger 
immunosuppressive effects on activated PBMCs
To investigate the immunomodulatory effects of 
cell supernatants on activated PBMCs, in vitro 
lymphocytes proliferation and migration assays were 
performed (Fig. 7a). PHA-activated PBMCs were 
incubated for 5 d in the presence or absence of serum-
containing CM from the different cell sources. The 
proliferation assay revealed that UCSC supernatants 
blocked PBMC proliferation (p = 0.06) when 
compared with PHA-treated controls (Fig. 7a,b). 
CM from ACs did not block PBMC proliferation, 
while HFPSCs (71 ± 5 %) and SMSCs (68 ± 3 %) had a 
minor effect. In the migration assay, both UCSCs and 
SMSCs blocked the migration of activated PBMCs 
as compared to positive controls (38 ± 2.5 % and 
38 ± 1.2 % vs. 44.2 ± 0.5 %, respectively) (Fig. 7b). To 
further investigate the immunomodulatory effects 
of MSC supernatants, the expression of TNF-α and 
IFN-γ in PBMCs-CM was measured. Values were 
normalised against residual expression levels present 
in supernatants of stromal cells. Supernatants from 
HFPSCs and SMSCs stimulated the production of 
TNF-α and IFN-γ above the levels achieved by PHA 
treatments. Importantly, supernatants from UCSCs 
suppressed the production of both TNF-α and IFN-γ 
by activated PBMCs, reaching significant differences 
when compared to HFPSCs (Fig. 7c).
Immunomodulatory properties of supernatants 
after stimulation of MSCs with pro-inflammatory 
cytokines
TGF-β1, PGE2, IL-4 and IL-10 were measured in 
the supernatants of stimulated and non-stimulated 
stromal cells by ELISA. Only TGF-β1 and PGE2 were 
detected in the supernatants of both stimulated and 
non-stimulated cells (Fig. 8a), whereas IL-4 and IL-10 
were not detected. In supernatants of cells stimulated 
with pro-inflammatory cytokines, the level of TGF-β1 
was increased in AC cultures (p = 0.09) but unchanged 
in SMSC and UCSC cultures. The amount of secreted 
PGE2 significantly increased in the supernatants of 
stimulated ACs and SMSCs (Fig. 8a). In addition, 
PBMC proliferation assay demonstrated superior 
blocking capacity of supernatants from primed adult 
stromal cells but not from UCSCs (Fig. 8b).
UCSC supernatants exerted superior anti-
inflammatory effects on M1 activated macrophages
Macrophage polarisation assays were performed as 
previously reported (Ambarus et al., 2012; Vogel et 
al., 2014). A panel of co-stimulatory molecules and 
Fig. 3. Comparative expression of selected proteins identified by LC/MS-MS belonging to specific 
pathways. Heat map showing proteins involved in (a) ECM remodelling (proteases and inhibitors), (b) 
cell signalling (growth factors) and (c) inflammation/immune responses. Down-regulated proteins are 
indicated in red, whereas up-regulated proteins in blue. 
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cytokines to characterise macrophage polarisation 
was chosen based on validation tests using different 
stimulants. Divergent expression of these markers 
was observed in the presence of different stimulants. 
In addition, IL-10 expression resulted to be an 
irrelevant marker for M2 polarised macrophages. In 
the validation test, increased IL-10 production was 
observed in the presence of LPS and IFN-γ (for M1 
induction) as compared to dexamethasone or TGF-β1 
and IL-4 stimulation (for M2 induction) (data not 
shown). These discrepancies are also reported by 
Chanteux et al. (2007) and Vogel et al. (2014). Moreover, 
CD163 was a suitable marker for dexamethasone-
stimulated M2 polarised macrophages but not 
for TGF-β1 and IL-4 stimulation. The discrepancy 
concerning the expression of M2 markers is also 
demonstrated by Jaguin et al. (2013).
 The immunomodulatory effects on M1 polarised 
macrophages were investigated by characterisation 
of surface marker expression (CD40, HLA-DR, 
CD64, CD80, CD86) and inflammatory cytokines 
release (Fig. 9). Supernatants from all stromal cell 
types suppressed the surface expression of HLA-
DR on activated macrophages, whereas only UCSC 
supernatants were able to significantly suppress the 
expression of CD40. On the other hand, supernatants 
from ACs were able to significantly increase the 
expression of the co-regulatory receptors CD80 and 
CD86 above the levels of M1 activation (Fig. 9b). 
In contrast to ACs and UCSCs, supernatants from 
HFPSCs and SMSCs increased the surface expression 
of CD64 above M1 activation levels. None of the 
supernatants was able to alter the expression of 
the M2 phenotype marker CD163. With regards to 
cytokine profiles, CM from all cell types was able to 
reduce the production of TNF-α, IL-6 and IL-12 by 
M1-M. Of note, a significant reduction of IL-6 and 
IL-12 concentration was only achieved by UCSCs 
(Fig. 9c).
Effects of UCSC CM on AC chondrogenesis
To check the chondrogenic potential of UCSC 
secretomes, the effects of UCSCs-CM on the 
expression of cartilage signature genes and the tissue-
forming capacity of dedifferentiated chondrocytes 
were investigated. Incubation with UCSCs-CM 
positively influenced gene expression of COL2A1, 
SOX9 and ACAN as compared to non-stimulated 
Fig. 4. Comparison of cytokines and chemokines from CM of ACs, HFPSCs, SMSCs and UCSCs. Dot 
density shows concentration of cytokines involved in inflammation (IL-4, IL-6, IL-8, IL-12, IL-17 and PGE2) 
and chemokines (MCP-1, MIP-1α and RANTES) detected in supernatants of four different stromal cell 
types. * p < 0.05; n = 4 donors/cell sources.
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Fig. 5. Comparison of MMPs and anabolic factors from CM of ACs, HFPSCs, SMSCs and UCSCs. Dot 
density shows the concentration of MMPs (MMP-1, MMP-3, MMP-7 and MMP-9) and growth factors 
(TGF-β1, bFGF and BMP-2) detected in supernatants of four different stromal cell types. * p < 0.05; n = 4 
donors/cell sources.
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control P3 chondrocytes (Fig. 10); however, the 
differences were not significant except for ACAN. 
The CM of both stimulated and non-stimulated 
UCSCs significantly upregulated the expression of 
ACAN as compared to the control P3 chondrocytes 
(Fig. 10). On the other hand, in the 3D culture assays, 
no differences were observed in cartilage neo-tissue 
formation by histology when comparing pellets 
incubated in the presence or absence of UCSCs-CM 
(Fig. 11).
Discussion
The main objective of the study was to ascertain 
which source of stromal cells possesses the most 
favourable secretome to promote tissue repair. Given 
the importance of the MSC paracrine signalling, 
large-scale comparative analyses of cell secretomes 
were performed and functional studies with cell 
supernatants were conducted on immune cells 
to compare the constitutive immunomodulatory 
capabilities of different MSCs. Overall, the results 
demonstrated that stromal cells from umbilical 
cord matrix exhibited superior anti-inflammatory 
and trophic effects when compared with adult ACs, 
HFPSCs and SMSCs.
 All cell sources were expanded in monolayer 
cultures in the serum-supplemented media for some 
weeks, as done in standard cell transplantation 
procedures. To facilitate the analyses of secretory 
profiles by LC-MS/MS proteomics, the media were 
conditioned under serum-free conditions. Multiplex 
protein arrays were performed with the same serum-
free CM that was used for proteomics, allowing direct 
comparisons of results. However, functional assays 
with immune cells were performed with serum-
supplemented CM, as serum deprivation affects 
proliferation and induces apoptosis in lymphocytes 
and macrophages, respectively (Sato et al., 2009; 
Wei et al., 2006). Short periods of serum deprivation 
do not affect the cell viability of mesenchymal cells 
(Boraldi et al., 2008). However, some changes in 
the secretome could occur upon changes in serum 
supplementation. Significantly higher expression 
of IL-6 was only observed in the presence of serum 
in all four cell types (Fig. 6). Although only minor 
phenotypic changes were expected in cells associated 
with serum presence, alterations in the expression of 
some bioactive molecules could occur and should be 
taken into consideration.
 Currently, MSCs are viewed as “drugstores” 
with the potential to modulate the phenotype, 
migration and activation of resident tissue and 
inflammatory cells (Caplan and Correa, 2011). This 
has led researchers to study MSC-mediated paracrine 
effects and profiles of secreted proteins from different 
mesenchymal stromal cell types. Previous studies 
comparing secretory profiles from different MSC 
sources highlight the existence of differentially 
expressed factors, with impact on angiogenesis, matrix 
remodelling, inflammation and immunosuppression 
(Amable et al., 2014; Dabrowski et al., 2017; Hsiao et 
al., 2012; Li et al., 2015). The qualitative analyses using 
a large-scale proteomic approach revealed similar 
protein profiles, where most of the identified proteins 
were present in all cell supernatants. However, after 
hierarchical clustering of protein profiles from all 
donors, UCSC secretomes single out from the other 
adult cell sources (Fig. 1b). Quantitative analyses of 
the secretome data revealed that proteins involved 
in cell signalling, such as TGF-β1 and PDGFD, were 
upregulated in UCSC supernatants, while catabolic 
proteins, such as MMPs, serpins and complement 
factors, were downregulated when compared to 
stromal cells from adult origin. TGF-β1 is a master 
driver of chondrogenesis and has pleiotropic effects 
in OA pathogenesis (Tang et al., 2015; Zhang et al., 
2015; Zhen et al., 2013). In addition, TGF-β1 has anti-
apoptotic effects (Rehman et al., 2004). Observations 
from other studies are disparate and include cell 
sources that were not used in the present study; 
Fig. 6. Cytokine expression by 
all cell sources in serum-free and 
serum-supplemented conditions. 
The secretion of selected cytokines 
and factors was assessed by ELISA. 
TNF-α, IFN-γ and IL-12 were not 
detected. Data were analysed using 
Mann-Whitney U comparison 
between serum-free and serum-
containing CM of each cell type. 
* p < 0.05; n = 4 donors/cell sources. 
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Fig. 7. Inhibition of PBMC activation by CM. (a) PBMC proliferation assay: representative flow cytometry 
dot plots depict the percentage of proliferating PBMCs stimulated with 10 µg/mL of PHA in the presence and 
absence of CM from the four different stromal cell types. (b) Quantitative analyses of PBMCs proliferation 
and migration in the presence and absence of CM from four different stromal cell types. 100 ng/mL SDF-1 
was used for chemo-attraction in migration assays. (c) Total concentration of TNF-α and IFN-γ detected 
in 106 cells/well PBMCs-CM after incubation with PHA and CM from four different stromal cell types. 
* p < 0.05; n = 4 donors/cell sources. 
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however, the superior anabolic phenotype of 
UCSCs, including  the highest expression of TGF-β1 
among the compared cell types, is also observed 
by Dabrowski et al. (2017). Data from the multiplex 
protein analyses revealed a significant reduction 
of MMPs and increased expression of TGF-β1 by 
UCSCs, thus reasserting observations made in the 
large-scale proteomic approach. Altogether, these 
observations highlighted the less catabolic phenotype 
of UCSCs when compared to the three other adult 
MSCs.
 The immunomodulatory profile of the different 
MSCs was also investigated by proteomics and 
multiplex arrays. Secretome analyses revealed 
comparable expression of complement components, 
heat-shock proteins, galectins and immunoregulators, 
such as CSF-1, MCP-1, MIF and TGF-β1, among 
the different cell sources. The data from multiplex 
protein arrays showed enhanced expression of the 
immunomodulators IL-6, MCP-1 and PGE2 and 
reduced expression of IL-17 and MIP-1α in UCSCs. 
Notably, stimulation of stromal cells with pro-
inflammatory cytokines increased the expression 
of PGE2 in all cell types. However, a limitation 
of the study was the relatively low number of 
biological replicates, where the inclusion of more 
biological replicates could prove to be statistically 
significant for most of the analysed cytokines. IL-6 
has an omnidirectional role in maintaining biological 
functions, whereas it has deleterious effects in the 
joint (Poree et al., 2008; Sui et al., 2009). However, 
selective depletion of IL-6 in animals is associated 
with accelerated joint degeneration upon ageing (de 
Hooge et al., 2005). Bouffi et al. (2010) demonstrate 
IL-6-dependent inhibition of local inflammation in 
experimental arthritis. MCP-1 (also called CCL2), 
MIP-1α (CCL3) and IL-17 are all potent inflammatory 
factors mediating recruitment and activation of 
myeloid cells. Their presence is associated with 
cartilage degeneration and progression of OA 
(Appleton et al., 2015; Snelling et al., 2017; Wang 
et al., 2017; Xu et al., 2015; Zhao et al., 2015). IL-17 
inhibits chondrogenesis and promotes MMPs in 
chondrocytes (Benderdour et al., 2002; Kondo et al., 
2013). PGE2 regulates phenotype and functions of 
pro-inflammatory macrophages and natural killer 
(NK) cells (Manferdini et al., 2017), however, the 
overall role of this factor in OA progression and 
Fig. 8. Immunomodulatory properties of ACs, SMSCs and UCSCs after stimulation with TNF-α and 
IFN-γ. Cells in monolayer culture (70-80 % confluence) were stimulated for 48 h with 50 ng/mL each of 
TNF-α and IFN-γ. Data were analysed using Mann-Whitney U comparison between non-stimulated and 
stimulated CM of each cell type. (a) Dot density shows the concentration of TGF-β1 and PGE2 detected in 
supernatants of non-stimulated and stimulated cell types. (b) PBMC proliferation assays in the presence 
of non-stimulated and stimulated CM of ACs, SMSCs and UCSCs. * p < 0.05; n = 3 donors/cell sources. 
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Fig. 9. UCSC secretomes could modulate macrophage-mediated inflammation. (a) Characterisation 
of surface molecules during polarisation of M0-M into M1-M (CD40, CD64, CD80, CD86 and HLA-DR) 
and M2-M (CD163) by flow cytometry. Red, blue and orange peaks represent isotype control, M0-M and 
activated macrophages, respectively. (b) Dot density depicts M1-M activation and distinct blocking of M1-M 
activation by CM from ACs, HFPSCs, SMSCs and UCSCs. M2-M polarisation was used as a negative control 
for surface expression of CD40 and HLA-DR. (c) Levels of TNF-α, IL-6 and IL-12 detected in macrophage 
culture CM (2.5 × 106 cells/well) after incubation with CM from four different stromal cell types. * p < 0.05; 
** p < 0.005; n = 4 donors/cell sources. 
cartilage homeostasis is still controversial (Bouffi et 
al., 2010; Miwa et al., 2000; Otsuka et al., 2009). Despite 
the difficulty to reach general conclusions due to the 
pleiotropic nature of many chemokines and cytokines, 
the observations based on the global expression of 
released factors indicated that UCSCs displayed a 
more immunosuppressive and anti-inflammatory 
phenotype than their adult counterparts.
 To investigate further the paracrine potential 
of the different MSCs on immunomodulation, 
functional assays were conducted on lymphocytes 
and macrophages. Results using functional assays 
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harmonised with protein profiles, highlighting the 
superior immunosuppressive phenotype of UCSCs 
as compared to the other MSCs. The MSC ability to 
regulate inflammation and immunity has been the 
focus of intense research over recent years (Donders 
et al., 2018; von Bahr et al., 2012). Many in vitro studies 
show that mesenchymal cells from multiple sources, 
including differentiated connective tissue cells, such 
as chondrocytes and fibroblasts, have the potential to 
regulate inflammation and T-cell functions to some 
extent (Bouffi et al., 2011; Lohan et al., 2016). Still, 
there is no consensus on which cell source is the 
most powerful in this respect. Most published studies 
compare bone marrow, adipose tissue and foetal 
tissues with different outcomes. Some comparative 
studies demonstrate that bone marrow MSCs have 
slightly superior immunosuppressive capacity than 
other MSCs (Heo et al., 2016; Karaoz et al., 2017). 
In line with the observations of the present study, 
some groups observe superior immunosuppressive 
abilities by MSCs from cords (Jin et al., 2013; Najar et 
al., 2012). The chondro-inductive potential of UCSC 
supernatants on dedifferentiated chondrocytes was 
also tested in the present study. Whilst cartilage 
reference genes were upregulated after incubation 
with UCSCs-CM, no clear differences where observed 
in 3D neo-tissue formation in vitro. These results 
put forward the anabolic potential of the UCSC 
secretome; however, the concentration of anabolic 
factors, such as TGF-β1, in supernatants remained 
insufficient to trigger proper chondrogenesis from 
dedifferentiated chondrocytes.
 Priming of MSCs is extensively documented and 
is recommended as a mandatory step to unleash the 
full immunosuppressive potential of MSCs (Gomez-
Aristizabal et al., 2017; Najar et al., 2012; van Buul et 
al., 2012). In the present study, stimulation of adult 
stromal cells with pro-inflammatory cytokines altered 
the expression of some immunoregulatory factors 
and increased the blocking effects over PBMCs by 
adult MSCs (Fig. 8). On the other hand, the effects 
exerted by primed UCSCs on PBMC proliferation 
were unchanged. These differences could be due to 
early embryonic differentiation of the cell phenotypes. 
Notably, constitutive immunoregulation by non-
stimulated UCSCs is observed in an OA rabbit model 
(Saulnier et al., 2015). In this context, ex vivo priming 
of MSCs is related to few controversial outcomes in 
vivo, describing increased immunogenicity of pre-
stimulated MSCs (Papadopoulou et al., 2012; Treacy 
et al., 2014).
 In clinical settings, MSCs from different sources 
are investigated for the treatment of focal cartilage 
lesions and OA (Lee and Wang, 2017). Articular 
Fig. 10. Effects of UCSCs-CM on cartilage signature gene expression of dedifferentiated chondrocytes 
in monolayer cultures. Relative expression of COL2A1, COL1A1, SOX9 and ACAN by chondrocytes in 
the presence of CM from stimulated and non-stimulated ACs and UCSCs. Dedifferentiated chondrocytes 
at P2 and P3 in the absence of CM were used as controls. p ˂ 0.05; n = 3 donors.
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chondrocytes, bone marrow and adipose tissue 
stromal cells are the most commonly used sources 
for cartilage repair (Vonk et al., 2015). These studies 
mostly assess safety and efficacy of used MSCs for 
specific clinical implications. A comparative study 
in humans argues that autologous SMSCs exert 
superior healing outcomes (Akgun et al., 2015). On the 
other hand, in preclinical models, MSCs from cords 
exert immunosuppression and disease regression 
in experimental models of OA and autoimmune 
disorders (Donders et al., 2015; Saulnier et al., 2015; 
Yang et al., 2015). In contrast to MSCs from autologous 
sources, there are only few ongoing trials exploring 
the potential of allogeneic UCSCs for both OA 
management and focal cartilage repair in humans 
(NCT02580695, NCT02291926, NCT03166865 and 
NCT03358654), without published outcomes hitherto. 
Confirming the results of the present comparative 
study in suitable animal models would provide more 
insight into the use of UCSCs for cartilage disorders 
in the clinics.
Conclusions
Traditionally, the regenerative potential of MSCs 
has been directly linked to their multipotent 
differentiation and tissue-forming capabilities. 
Nowadays, increasing attention is given to their 
role as paracrine modulators. In the field of articular 
cartilage lesions and degenerative joint diseases, there 
is no consensus on the best cell source for treatment. 
Considering the relevance of paracrine signalling, 
the present study compared the secretome among 
MSCs from different sources. Both the molecular 
analyses and the functional assays indicated that 
UCSCs displayed superior anti-inflammatory and 
trophic effects when compared to MSCs from adult 
Fig. 11. Effects of CM on 
in vitro chondrogenesis of 
dedifferentiated chondrocytes. 
Spheroids (n = 2 donors) were 
generated by pellet culture 
method and harvested after 
21 d of chondrogenesis for 
histological evaluation. Bright 
light microscopy images of 
alcian-blue-stained spheroids 
(4 µm-thick sections) show (a) 
no growth factor, (b) TGF-β1 
and BMP-2, (c) AC CM, (d) 
primed AC CM, (e) SMSC CM, 
(f) primed SMSC CM, (g) UCSC 
CM and (h) primed UCSC CM. 
Scale bar: 200 µm. 
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tissues. The hypoimmunogenic nature of UCSCs, 
along with their high abundance, simple isolation 
and favourable protein profiles make this cell source 
an attractive tool for off-the-shelf allogeneic adjuvant 
therapy.
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Discussion with Reviewers
Andrea Barbero: The authors have analysed the 
secretome of different MSCs after their in vitro 
culture. However, the secretion profile of cells can 
drastically change after their injection in the joint (i.e. 
an environment that is extremely more complex that 
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the in vitro one). Can the authors state their opinion 
on this issue?
Authors: We agree with the reviewer on the likelihood 
of cells displaying different secretome in vitro and in 
joint conditions. Unfortunately, the technology to 
assess the secretory profile of the implanted MSCs 
in vivo was not available. To shed some light on this 
point, cells were stimulated in vitro with a cocktail 
of inflammatory cytokines. Results showed that 
adult MSCs became more immunosuppressive in 
inflammatory environments. This point has also been 
discussed in the manuscript.
Lucienne Vonk: For future purposes, how do you 
envision to produce a well-characterised and quality-
controlled product from the secretome of stromal 
cells?
Authors: To produce a well-characterised and 
quality-controlled product from the secretome of 
stromal cells is almost as complicated as to produce 
a quality-controlled and well-characterised product 
from stromal cells per se. As shown in the proteomic 
analyses, secretomes from stromal cells contained 
(at least) more than 500 different proteins and it 
was difficult to speculate which individual factor or 
cocktail of factors might play a role in inflammation or 
tissue repair. Most probably different paracrine signal 
molecules act concomitantly. A well-characterised 
product would require knowing exactly which 
molecules are present in the product and what would 
be the precise effect of those bioactive factors. Actions 
that could help to move in that direction would 
include characterisation of samples by fractionation 
(for example molecular size). Specific blockade of 
distinct factors would also help to ascertain which 
factors from the entire secretome are more relevant 
to induce repair. One possibility is that the effects of 
CM would come from the extracellular vesicles. In 
this case, the complexity of the sample preparation 
would be reduced. Still, a well-characterised product 
would require a thorough characterisation of the 
extracellular vesicles and the determination of the 
effector molecule(s) which could include miRNA 
or other non-protein molecules. Most probably the 
effects from stromal cells secretome are multifactorial 
and not reduced to one or a handful of factors, so that 
the manufacture of a well-characterised and quality-
controlled product for its safe use in clinics is close 
to an oxymoron.
Yuk Wai Lee: How did the authors ensure they 
were detecting secretory cytokines but not residual 
cytokines from the serum or cytokines released from 
the cells due to cell damage/death?
Authors: Residual amounts of serum proteins could 
be present in the experimental samples. However, 
after extensive washings, only very abundant serum 
proteins, such as albumin or immunoglobulins, can 
be detected by MS. In any case, this aspect would 
be equal for all experimental samples and would 
not have an impact on the outcomes of the study, 
which focussed on differences between experimental 
groups. The same argument applied to proteins 
derived from dead cells. Notably, the extent of cell 
death in cultures at the time of supernatants collection 
(from all cell sources) was negligible/undetectable by 
trypan blue exclusion.
Katie Lee: Why did the authors choose to culture 
the cells in normoxic conditions, rather than more 
physiologically relevant hypoxic conditions?
Authors: It could be interesting to check hypoxic 
culture conditions. Surface markers characterisation 
of MSCs is routinely performed by the authors, 
showing no significant differences in surface markers 
expression during monolayer culture in high or 
low oxygen tensions. In our experience, hypoxic 
environments play a more important role in 3D 
cultures and chondrogenesis. Therefore, normoxic 
conditions were used in the study.
Katie Lee: How did the authors confirm the cell types 
isolated in the study were actually MSCs and not 
fibroblasts or other forms of progenitor cell?
Authors: MSCs were referred to as mesenchymal 
stromal cells (not stem cells), emphasising on the 
stromal origin more than the stem cell or progenitor 
nature. This was consciously done taking into 
consideration that it is very difficult to differentiate 
between progenitor cells, fibroblasts or other type of 
stromal cells based on phenotypic markers or even 
on their multi-differentiation. By using the term 
mesenchymal stromal cells, the potential problem 
with semantics was circumvented.
Editor’s note: The Scientific Editor responsible for 
this paper was Christine Hartmann.
